help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rivier, C.
Right arrow Articles by Vale, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rivier, C.
Right arrow Articles by Vale, W.

Endocrinology, Vol 103, 2299-2305, Copyright © 1978 by Endocrine Society


ARTICLES

Chronic effects of [D-Trp6-Pro9-NEt]luteinizing hormone-releasing factor on reproductive processes in the female rat

C Rivier, J Rivier and W Vale

LRF and one of its highly potent analogs, [D-Trp6-Pro9-NEt]LRF (A), were tested for their effects on pregnancy. Daily doses of A prevented implantation and/or caused resorption of implanted blastocysts in mated female rats. This effect was dose related and was most evident when given in regimens including days 5-7 or days 9-10 or pregnancy. LRF also has antigonadal effects, but at much higher doses than A. The use of corn oil vs. 0.1% gelatin-saline improved the effectiveness of low doses of A. Termination of pregnancy in A- or LRF-treated rats is most probably due to the markedly diminished progesterone secretion, which could result from the secretion of biologically inactive gonadotropins, reduced pituitary responsiveness to endogenous LRF, or down-regulation of gonadal receptors for LH.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. Princivalle, P. Broqua, R. White, J. Meyer, G. Mayer, L. Elliott, K. Bjarnason, R. Haigh, and C. Yea
Rapid Suppression of Plasma Testosterone Levels and Tumor Growth in the Dunning Rat Model Treated with Degarelix, a New Gonadotropin-Releasing Hormone Antagonist
J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1113 - 1118.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
R. Guillemin
Hypothalamic hormones a.k.a. hypothalamic releasing factors
J. Endocrinol., January 1, 2005; 184(1): 11 - 28.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
H. Yang, G. K. Bhat, R. Wadley, K. L. Wright, B. M. Chung, J. A. Whittaker, A. M. Dharmarajan, and R. Sridaran
Gonadotropin-Releasing Hormone-Agonist Inhibits Synthesis of Nitric Oxide and Steroidogenesis by Luteal Cells in the Pregnant Rat
Biol Reprod, June 1, 2003; 68(6): 2222 - 2231.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
R. Casper and S. Yen
Induction of luteolysis in the human with a long-acting analog of luteinizing hormone-releasing factor
Science, July 27, 1979; 205(4404): 408 - 410.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1978 by The Endocrine Society